Adage Capital Partners
GMED icon

Adage Capital Partners’s Globus Medical GMED Stock Holding History

Adage Capital Partners’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-400,000
Closed -$21.5M – 898
2024
Q1 		$21.5M Buy
400,000
+200,000
+100% +$10.8M 0.04% 429
2023
Q4 		$10.7M Buy
+200,000
New +$9.75M 0.02% 577
2023
Q2 		– Sell
-56,165
Closed -$3.18M – 891
2023
Q1 		$3.18M Buy
+56,165
New +$3.6M 0.01% 744
2018
Q4 		– Sell
-60,000
Closed -$3.41M – 728
2018
Q3 		$3.41M Buy
+60,000
New +$3.16M 0.01% 658
2018
Q1 		– Sell
-160,000
Closed -$6.58M – 739
2017
Q4 		$6.58M Buy
160,000
+60,000
+60% +$2.1M 0.01% 609
2017
Q3 		$2.97M Sell
100,000
-50,000
-33% -$1.53M 0.01% 657
2017
Q2 		$4.97M Sell
150,000
-50,000
-25% -$1.57M 0.01% 635
2017
Q1 		$5.92M Buy
+200,000
New +$5.46M 0.01% 599
2015
Q4 		– Sell
-200,000
Closed -$4.13M – 709
2015
Q3 		$4.13M Hold
200,000
– – 0.01% 628
2015
Q2 		$5.13M Sell
200,000
-200,000
-50% -$5.06M 0.01% 633
2015
Q1 		$10.1M Sell
400,000
-50,000
-11% -$1.22M 0.02% 549
2014
Q4 		$10.7M Sell
450,000
-500,000
-53% -$11.1M 0.03% 534
2014
Q3 		$18.7M Sell
950,000
-75,000
-7% -$1.54M 0.05% 409
2014
Q2 		$24.5M Sell
1,025,000
-175,000
-15% -$4.22M 0.06% 348
2014
Q1 		$31.9M Sell
1,200,000
-232,652
-16% -$5.53M 0.09% 278
2013
Q4 		$28.9M Buy
1,432,652
+634,652
+80% +$11.8M 0.08% 318
2013
Q3 		$13.9M Buy
798,000
+547,300
+218% +$9.47M 0.04% 440
2013
Q2 		$4.23M Buy
+250,700
New +$3.87M 0.01% 604

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Adage Capital Partners's GMED Position: Q2 2024 in Review

Adage Capital Partners sold out of Globus Medical (GMED) in Q2 2024, closing a stake of 400,000 shares — an estimated $21.5M sold.

Adage Capital Partners first reported a position in GMED in Q2 2013 and held it in 18 quarters. The position peaked at $31.9M in Q1 2014. 450 funds tracked by Wall St. Rank hold GMED as of Q2 2024.

  • Adage Capital Partners reported no remaining Globus Medical position as of Q2 2024 after selling out during the quarter.
  • Adage Capital Partners sold 400,000 Globus Medical shares in Q2 2024, an estimated $21.5M.
  • Adage Capital Partners first reported a position in Globus Medical in Q2 2013 and held it in 18 quarters.
  • Adage Capital Partners's Globus Medical position peaked at $31.9M in Q1 2014.
  • 450 funds tracked by Wall St. Rank held Globus Medical as of Q2 2024.

Based on Adage Capital Partners's 13F filing for Q2 2024, filed 14 Aug 2024.